date,title,source
Oct-18-18,"Investor Expectations to Drive Momentum within Amkor Technology, Lexicon Pharmaceuticals, Parker Drilling, HFF, The Chefs' Warehouse, and Payment Data  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-25-18,"Lexicon Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on November 1, 2018",GlobeNewswire
Nov-01-18,Edited Transcript of LXRX earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Lexicon: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Lexicon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides a Business Update,GlobeNewswire
Nov-05-18,3 Top Small-Cap Stocks to Buy Right Now,Motley Fool
Nov-05-18,Edited Transcript of LXRX earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Edited Transcript of LXRX earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,GlobeNewswire
Nov-08-18,Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,GlobeNewswire
Nov-12-18,"Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-23-18,Should You Worry About Lexicon Pharmaceuticals Incs (NASDAQ:LXRX) CEO Pay Cheque?,Simply Wall St.
Nov-29-18,FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes,GlobeNewswire
Dec-11-18,3 Top Biotech Stocks to Buy in December,Motley Fool
Dec-18-18,Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211,GlobeNewswire
Dec-20-18,Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes,GlobeNewswire
Dec-21-18,Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,GlobeNewswire
Jan-07-19,"Lexicon Pharmaceuticals has Upcoming FDA Dates, Phase I Results, Analysts Review and Target",ACCESSWIRE
Jan-17-19,Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes,GlobeNewswire
Jan-17-19,"Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes",GlobeNewswire
Jan-17-19,FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults With Type 1 Diabetes,GlobeNewswire
Jan-17-19,Lexicon Pharmaceuticals stock to be halted Thursday as FDA committee reviews diabetes treatment,MarketWatch
Jan-17-19,Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for the Treatment of Type 1 Diabetes,GlobeNewswire
Jan-18-19,Here's Why Lexicon Pharmaceuticals Collapsed Today,Motley Fool
Jan-18-19,"The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug",Benzinga
Jan-22-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX",PR Newswire
Jan-22-19,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Lexicon Pharmaceuticals, Inc. (LXRX)",GlobeNewswire
Jan-24-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX",GlobeNewswire
Jan-29-19,"Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.",Business Wire
Jan-29-19,About to Buy Penny Stocks? Look at These 3 Companies First,Motley Fool
Jan-30-19,"LEXICON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",PR Newswire
Jan-30-19,"Robbins Arroyo LLP: Lexicon Pharmaceuticals, Inc. (LXRX) Misled Shareholders According to a Recently Filed Class Action",Business Wire
Jan-30-19,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Jan-31-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  LXRX",ACCESSWIRE
Jan-31-19,"Research Report Identifies Knight-Swift Transportation, Alteryx, Lexicon Pharmaceuticals, Procter & Gamble, MicroStrategy, and SMART SAND INC with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Feb-01-19,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-04-19,"Lawsuit for Investors in Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced by Shareholders Foundation",ACCESSWIRE
Feb-05-19,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-06-19,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-08-19,"RM LAW Announces Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.",PR Newswire
Feb-11-19,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-11-19,Here's Why Lexicon Pharmaceuticals Lost 28.8% in January,Motley Fool
Feb-12-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  LXRX",ACCESSWIRE
Feb-13-19,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-13-19,"New Research: Key Drivers of Growth for WPX Energy, ACADIA Pharmaceuticals, Lexicon Pharmaceuticals, MobileIron, Arrow Electronics, and Abeona Therapeutics  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Feb-14-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  LXRX",GlobeNewswire
Feb-14-19,"Lifshitz & Miller LLP Announces Investigation of Arlo Technologies, Inc., Alkermes Public Limited Company, Lexicon Pharmaceuticals, Inc., BSB Bancorp, Inc., Markel Corporation, Natural Health Trends Corp., and Nova Lifestyle, Inc.",PR Newswire
Feb-15-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-15-19,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-15-19,"Lexicon Pharmaceuticals, Inc. (LXRX), ProShares Short VIX Short-Term Futures ETF (SVXY) & Alta Mesa Resources, Inc. f/k/a Silver Run Acquisition Corporation II (AMR) Bronstein, Gewirtz & Grossman, LLC Class Action Update",ACCESSWIRE
Feb-19-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-19-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-19-19,"Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX) Bronstein, Gewirtz & Grossman, LLC Class Action Update",ACCESSWIRE
Feb-20-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-20-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-20-19,"Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX) Bronstein, Gewirtz & Grossman, LLC Class Action Update",ACCESSWIRE
Feb-22-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-22-19,"SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-22-19,"Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX) Bronstein, Gewirtz & Grossman, LLC Class Action Update",ACCESSWIRE
Feb-25-19,"INVESTOR ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Deadline: April 1, 2019",ACCESSWIRE
Feb-25-19,"INVESTOR ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-25-19,"VALE, LXRX & SVXY INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action",ACCESSWIRE
Feb-26-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - LXRX",PR Newswire
Feb-26-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",ACCESSWIRE
Feb-26-19,"Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-26-19,"Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-26-19,"VALE, LXRX & SVXY ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action",ACCESSWIRE
Feb-27-19,"Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-27-19,"Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action & Lead Plaintiff Deadline: April 1, 2019",ACCESSWIRE
Feb-27-19,"VALE, LXRX & SVXY: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action",ACCESSWIRE
Feb-28-19,Lexicon Pharmaceuticals Announces Poster Presentations at the 16th Annual ENETS Conference,GlobeNewswire
Feb-28-19,"Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Deadline: April 1, 2019",ACCESSWIRE
Mar-01-19,Here's Why Lexicon Pharmaceuticals Jumped as Much as 26.9% Today,Motley Fool
Mar-01-19,Sanofi : CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes,GlobeNewswire
Mar-01-19,CHMP Recommends Zynquista (Sotagliflozin) for the Treatment of Adults With Type 1 Diabetes,GlobeNewswire
Mar-04-19,"(LXRX) Lexicon Pharmaceuticals, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action & Deadline: April 1, 2019",ACCESSWIRE
Mar-04-19,"INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX), ProShares Short VIX Short-Term Futures ETF (SVXY) & Alta Mesa Resources, Inc. f/k/a Silver Run Acquisition Corporation II (AMR)",ACCESSWIRE
Mar-05-19,"STOCKHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX), ProShares Short VIX Short-Term Futures ETF (SVXY) & Alta Mesa Resources, Inc. f/k/a Silver Run Acquisition Corporation II (AMR)",ACCESSWIRE
Mar-05-19,"Deadline in Lawsuit for Investors in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced by Shareholders Foundation",GlobeNewswire
Mar-08-19,"Zacks.com featured highlights include: Lexicon, Medtronic and NetApp",Zacks
Mar-11-19,"Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call and Webcast on March 13, 2019",GlobeNewswire
Mar-11-19,"(LXRX) Lexicon Pharmaceuticals, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action & Deadline: April 1, 2019",ACCESSWIRE
Mar-11-19,Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,GlobeNewswire
Mar-12-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  LXRX",ACCESSWIRE
Mar-12-19,"(LXRX) Lexicon Pharmaceuticals, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action & Deadline: April 1, 2019",ACCESSWIRE
Mar-12-19,Do Options Traders Know Something About Lexicon Pharmaceuticals (LXRX) Stock We Don't?,Zacks
Mar-13-19,"Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Mar-13-19,"Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Mar-13-19,Lexicon: 4Q Earnings Snapshot,Associated Press
Mar-13-19,Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides a Business Update,GlobeNewswire
Mar-13-19,"Lexicon Pharmaceuticals, Inc. to Host Earnings Call",ACCESSWIRE
Mar-15-19,"(LXRX) Lexicon Pharmaceuticals, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action & Deadline: April 1, 2019",GlobeNewswire
Mar-15-19,"Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl in Biliary Tract Cancer",GlobeNewswire
Mar-15-19,"Lexicon Pharmaceuticals Inc (LXRX) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Mar-15-19,Edited Transcript of LXRX earnings conference call or presentation 13-Mar-19 12:00pm GMT,Thomson Reuters StreetEvents
Mar-18-19,"GSM, TYME & LXRX - Bronstein, Gewirtz & Grossman, LLC Class Action",ACCESSWIRE
Mar-18-19,Lexicon Pharma Initiates Dosing in Biliary Tract Cancer Study,Zacks
Mar-19-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  LXRX",ACCESSWIRE
Mar-19-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Lexicon Pharmaceuticals, Inc. to Contact The Firm",Business Wire
Mar-20-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Lexicon Pharmaceuticals, Inc. to Contact the Firm",GlobeNewswire
Mar-20-19,"GSM, TYME & LXRX - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder",ACCESSWIRE
Mar-20-19,Edited Transcript of LXRX earnings conference call or presentation 13-Mar-19 12:00pm GMT,Thomson Reuters StreetEvents
Mar-21-19,"Class Action Reminder GSM, TYME & LXRX - Bronstein, Gewirtz & Grossman, LLC",GlobeNewswire
Mar-22-19,This Pharma Giant Slipped After FDA Rejected Its Diabetes Treatment,Investor's Business Daily
Mar-22-19,"Why Zuora, Greenbrier, and Lexicon Pharmaceuticals Slumped Today",Motley Fool
Mar-22-19,FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes,Reuters
Mar-22-19,Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin),GlobeNewswire
Mar-22-19,"Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes",GlobeNewswire
Mar-22-19,FDA Issues Complete Response Letter for Zynquista (sotagliflozin),GlobeNewswire
Mar-22-19,"Class Action Reminder GSM, TYME & LXRX - Bronstein, Gewirtz & Grossman, LLC",ACCESSWIRE
Mar-25-19,Lexicon Falls as FDA Denies Approval to Type I Diabetes Drug,Zacks
Mar-25-19,AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes,Zacks
Mar-25-19,What's Next for Lexicon Pharmaceuticals?,Motley Fool
Mar-26-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",ACCESSWIRE
Mar-26-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - LXRX",ACCESSWIRE
Mar-27-19,"Biotech Stock Roundup: BIIB &amp; CNAT Crash on Study Failures, LXRX Gets CRL",Zacks
Mar-27-19,"Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action",ACCESSWIRE
Mar-27-19,"Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX)",GlobeNewswire
Mar-28-19,"CLASS ACTION UPDATE for LXRX, UXIN and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",ACCESSWIRE
Mar-28-19,AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes,Zacks
Mar-29-19,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LXRX, UXIN, AVEO and AMRN",GlobeNewswire
Mar-29-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",GlobeNewswire
Apr-01-19,"CLASS ACTION UPDATE for LXRX, BRS, WTW and AMR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Apr-01-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",ACCESSWIRE
Apr-01-19,"FINAL DEADLINE - (LXRX) Lexicon Pharmaceuticals, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action & Deadline: April 1, 2019",ACCESSWIRE
Apr-02-19,Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,GlobeNewswire
Apr-03-19,Did You Manage To Avoid Lexicon Pharmaceuticals's (NASDAQ:LXRX) Painful 55% Share Price Drop?,Simply Wall St.
